rs1147129

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007347.5(AP4E1):​c.222+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.551 in 1,603,050 control chromosomes in the GnomAD database, including 245,547 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 24500 hom., cov: 33)
Exomes 𝑓: 0.55 ( 221047 hom. )

Consequence

AP4E1
NM_007347.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.00700

Publications

16 publications found
Variant links:
Genes affected
AP4E1 (HGNC:573): (adaptor related protein complex 4 subunit epsilon 1) This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
AP4E1 Gene-Disease associations (from GenCC):
  • AP-4 deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 51
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • AP4-related intellectual disability and spastic paraplegia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 15-50912167-G-A is Benign according to our data. Variant chr15-50912167-G-A is described in ClinVar as [Benign]. Clinvar id is 380768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP4E1NM_007347.5 linkc.222+18G>A intron_variant Intron 2 of 20 ENST00000261842.10 NP_031373.2 Q9UPM8-1B4DM48

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP4E1ENST00000261842.10 linkc.222+18G>A intron_variant Intron 2 of 20 1 NM_007347.5 ENSP00000261842.5 Q9UPM8-1
AP4E1ENST00000560508.1 linkc.-27+18G>A intron_variant Intron 2 of 20 1 ENSP00000452976.1 Q9UPM8-2
AP4E1ENST00000558439.5 linkn.222+18G>A intron_variant Intron 2 of 20 1 ENSP00000452712.1 H0YK95
AP4E1ENST00000561393.5 linkn.-27+18G>A intron_variant Intron 2 of 19 1 ENSP00000452711.1 H0YK94

Frequencies

GnomAD3 genomes
AF:
0.566
AC:
85913
AN:
151904
Hom.:
24490
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.606
Gnomad AMI
AF:
0.479
Gnomad AMR
AF:
0.613
Gnomad ASJ
AF:
0.654
Gnomad EAS
AF:
0.414
Gnomad SAS
AF:
0.618
Gnomad FIN
AF:
0.577
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.533
Gnomad OTH
AF:
0.568
GnomAD2 exomes
AF:
0.570
AC:
143375
AN:
251352
AF XY:
0.569
show subpopulations
Gnomad AFR exome
AF:
0.602
Gnomad AMR exome
AF:
0.672
Gnomad ASJ exome
AF:
0.649
Gnomad EAS exome
AF:
0.428
Gnomad FIN exome
AF:
0.573
Gnomad NFE exome
AF:
0.540
Gnomad OTH exome
AF:
0.569
GnomAD4 exome
AF:
0.549
AC:
796634
AN:
1451028
Hom.:
221047
Cov.:
31
AF XY:
0.550
AC XY:
397446
AN XY:
722558
show subpopulations
African (AFR)
AF:
0.614
AC:
20441
AN:
33276
American (AMR)
AF:
0.663
AC:
29660
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.657
AC:
17127
AN:
26072
East Asian (EAS)
AF:
0.424
AC:
16782
AN:
39614
South Asian (SAS)
AF:
0.611
AC:
52568
AN:
86006
European-Finnish (FIN)
AF:
0.566
AC:
30245
AN:
53406
Middle Eastern (MID)
AF:
0.637
AC:
3666
AN:
5752
European-Non Finnish (NFE)
AF:
0.538
AC:
592965
AN:
1102164
Other (OTH)
AF:
0.553
AC:
33180
AN:
60032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
17385
34770
52154
69539
86924
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16910
33820
50730
67640
84550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.565
AC:
85962
AN:
152022
Hom.:
24500
Cov.:
33
AF XY:
0.568
AC XY:
42182
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.606
AC:
25144
AN:
41478
American (AMR)
AF:
0.612
AC:
9349
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.654
AC:
2268
AN:
3470
East Asian (EAS)
AF:
0.413
AC:
2134
AN:
5162
South Asian (SAS)
AF:
0.616
AC:
2971
AN:
4820
European-Finnish (FIN)
AF:
0.577
AC:
6080
AN:
10546
Middle Eastern (MID)
AF:
0.616
AC:
181
AN:
294
European-Non Finnish (NFE)
AF:
0.533
AC:
36201
AN:
67964
Other (OTH)
AF:
0.569
AC:
1201
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1929
3859
5788
7718
9647
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.554
Hom.:
8205
Bravo
AF:
0.571
Asia WGS
AF:
0.521
AC:
1814
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 51 Benign:3
May 31, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 01, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
11
DANN
Benign
0.79
PhyloP100
0.0070
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1147129; hg19: chr15-51204364; COSMIC: COSV55917175; COSMIC: COSV55917175; API